(Q83141003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Mutational patterns in the frameshift-regulating site of HIV-1 selected by protease inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Rolf Kaiser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Elena Knops

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Léa Brakier-Gingras

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eugen Schülter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Herbert Pfister

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Jens Verheyen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

27 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

Medical Microbiology and Immunology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

213-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22200908%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00430-011-0224-z

19 January 2020

exact match

0 references

cites work

The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes

1 reference

12 December 2020

Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients

1 reference

12 December 2020

Structure-function analysis of the ribosomal frameshifting signal of two human immunodeficiency virus type 1 isolates with increased resistance to viral protease inhibitors

1 reference

12 December 2020

Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation

1 reference

12 December 2020

A dual-luciferase reporter system for studying recoding signals

1 reference

12 December 2020

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism

1 reference

12 December 2020

Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability

1 reference

12 December 2020

Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1.

1 reference

12 December 2020

The evolution of protease mutation 76V is associated with protease mutation 46I and gag mutation 431V.

1 reference

12 December 2020

Predicting Bevirimat resistance of HIV-1 from genotype

1 reference

12 December 2020

Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.

1 reference

12 December 2020

Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1.

1 reference

12 December 2020

HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany

1 reference

12 December 2020

Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany

1 reference

12 December 2020

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays

1 reference

12 December 2020

Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates

1 reference

12 December 2020

Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity

1 reference

12 December 2020

Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease

1 reference

12 December 2020

Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response

1 reference

12 December 2020

Prevalence of C-terminal gag cleavage site mutations in HIV from therapy-naïve patients.

1 reference

12 December 2020

Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients

1 reference

12 December 2020

Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing

1 reference

12 December 2020

Analysis of natural variants of the human immunodeficiency virus type 1 gag-pol frameshift stem-loop structure

1 reference

12 December 2020

Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication

1 reference

12 December 2020

Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates

1 reference

12 December 2020

High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates

1 reference

12 December 2020

Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss

1 reference

12 December 2020

Novel Gag-Pol frameshift site in human immunodeficiency virus type 1 variants resistant to protease inhibitors

1 reference

12 December 2020